Tianjin Institute of Neurology, Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.
BloodWorks Research Institute, Seattle, WA, United States.
Front Immunol. 2023 Mar 9;14:1140501. doi: 10.3389/fimmu.2023.1140501. eCollection 2023.
Transcription factors bind promoter or regulatory sequences of a gene to regulate its rate of transcription. However, they are also detected in anucleated platelets. The transcription factors RUNX1, GATA1, STAT3, NFκB, and PPAR have been widely reported to play key roles in the pathophysiology of platelet hyper-reactivity, thrombosis, and atherosclerosis. These non-transcriptional activities are independent of gene transcription or protein synthesis but their underlying mechanisms of action remain poorly defined. Genetic and acquired defects in these transcription factors are associated with the production of platelet microvesicles that are known to initiate and propagate coagulation and to promote thrombosis. In this review, we summarize recent developments in the study of transcription factors in platelet generation, reactivity, and production of microvesicles, with a focus on non-transcriptional activities of selected transcription factors.
转录因子结合基因的启动子或调控序列以调节其转录速率。然而,它们也在无核血小板中被检测到。转录因子 RUNX1、GATA1、STAT3、NFκB 和 PPAR 已被广泛报道在血小板高反应性、血栓形成和动脉粥样硬化的病理生理学中发挥关键作用。这些非转录活性不依赖于基因转录或蛋白质合成,但它们的作用机制仍不清楚。这些转录因子的遗传和获得性缺陷与血小板微泡的产生有关,已知血小板微泡会引发和促进凝血和血栓形成。在这篇综述中,我们总结了转录因子在血小板生成、反应性和微泡产生中的研究进展,重点介绍了选定转录因子的非转录活性。